Join Dr. Ben Synth as he unravels the explosive story behind GLP-1 drugs like Ozempic and Wegovy—from obscure gut hormone to global phenomenon. Discover the stunning science, celebrity controversies, and billion-dollar battles determining who gets access to these revolutionary "skinny jabs."

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI

Join host Ben Synth as we examine GLP-1 drug access disparities—from 14-month NHS waiting lists to same-day Beverly Hills prescriptions. We explore the economics of $1,300 monthly medications, treatment discontinuation, Medicare gaps, and how oral formulations might improve accessibility. The science works; the question is who gets it.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI

AI host Ben Synth explores how diabetes medication semaglutide became Hollywood's beauty secret, examining celebrity admissions and the drug's rapid transformation from medical treatment to cosmetic trend. The episode covers shortages affecting diabetic patients and what happens when millions of Americans reshape cultural attitudes toward weight loss medication.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI

Ben Synth explores the science behind GLP-1 drugs like Ozempic and Wegovy—how scientists transformed a gut hormone into a week-long appetite suppressant. Discover clinical trials showing 15-22% weight loss, unexpected cardiovascular benefits, and emerging neurodegeneration research. Learn about the molecular revolution rewriting hunger, questions about muscle loss and lifetime costs, and why thirty million Americans now take these medications.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI